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Abstract 
The  foreign  body  reaction  (FBR)  is  the  first  reaction  of  the  nonspecific  immune  system 
against an implanted device and is characterized by the formation of a fibrotic tissue around 
the implant. In the case of interfaces for peripheral nerves, used to stimulate specific group 
of axons and to record different nerve signals, it has been shown that FBR could reduce its 
functionality  over  time  due  to  the  physical  separation  between  nerve  fibers  and  the 
interface caused by matrix deposition.  
In  order  to  understand  how  the  FBR  to  intraneural  interfaces  evolves,  polyimide  non‐
functional  devices  were  implanted  in  rat  peripheral  nerve.  First,  functional  studies  with 
electrophysiological, pain and locomotion tests demonstrate that implanted devices do not 
cause any alteration in nerve function. Besides, histological evaluation shows no alterations 
in myelinated axons or nerve architecture. Regarding the inflammatory response due to the 
implantation  surgery,  it  is decreased after 2 weeks, whereas  it  is  greater  in  the  implanted 
nerves and peaks after 2 weeks. With regard to tissue deposition surrounding the implant, a 
tissue capsule soon appears around the devices, acquiring  its maximum 2 weeks after and 
being  remodeled  subsequently.  Immunohistochemical  analysis  reveals  two  different  cell 
types  implicated  in  the  FBR  in  nerve:  macrophages  as  the  first  cells  in  contact  with  the 
interface and fibroblasts that appear later on in the edge of the capsule. 
   
1. Introduction 
Neuroprostheses aimed to restore the loss of motor and sensory function after a limb 
amputation try to link the peripheral nervous system with electromechanical prostheses by 
means of neural electrodes. Advanced neuroprostheses rely on the capability to interface 
specific groups of nerve fibers within the nerve for obtaining different motor signals and for 
stimulating selective populations of sensory afferents. Intraneural electrodes are considered 
as the most adequate type, as they allow for higher selectivity of recording and stimulation, 
lower intensity for stimulation and increased signal-to-noise ratio of recordings compared to 
extraneural electrodes  (1),(2). Several intraneural electrodes, such as multielectrode arrays (3)–
(7), longitudinal (LIFE) (8),(9) and transversal (TIME); (10),(11) intrafascicular electrodes have 
shown good performance for the bidirectional interface with the peripheral nerve. Intraneural 
electrodes should remain within the nerve for months or years and be able to record high 
quality motor nerve signals and to selectively stimulate small groups of afferent axons to 
evoke sensory activity for a successful performance over time Consequently, they have to 
show good biocompatibility and stability (12)–(15). 
However, during chronic implantations made in human subjects, it has been observed a 
reduction in the functionality of electrode active sites along time (13),(14),(16), thus limiting the 
prospective use of intraneural electrodes. Such failures have been attributed to 
electromechanical erosion of the metal sites and fatigue of the connections, and to the 
biological response of the nerve tissue against the electrode implant. Regarding the latter, 
experimental studies have reported that the implanted electrode becomes encapsulated by 
host cells, creating a separation between the electrode and the nerve fibers to be interfaced  
(9),(10),(17),(18).  
The foreign body reaction (FBR) is the first response of the nonspecific immune system 
against an implanted device. It is characterized by a primarily inflammatory phase triggered 
by macrophages and leukocytes, that is followed by a fibrotic phase in which fibroblasts are 
responsible for the formation of a fibrotic tissue around the implant (19). Despite the FBR has 
   
been widely studied and the progression of this response is well known in subcutaneous (20)–
(22), peritoneal (23),(24), and even central nervous system implants (25)–(27), few studies have 
focused in the peripheral nervous system (28)–(30) and a detailed description of the long-term 
response against implanted interfaces in peripheral nerves is still needed. In order to 
characterize the cellular processes participating in the FBR to an intraneural electrode, which 
may allow to identify new targets to modulate this response and enhance the interface 
functionality, we have studied from 1 day to 8 months the progression of the FBR to 
longitudinal nerve implants made of polyimide, a material widely used in the fabrication of 
peripheral nerve interfaces (9),(11),(18),(31) in the rat sciatic nerve.  
   
2. Material and Methods 
2.1 Animals and surgical procedures 
Female Sprague-Dawley rats weighing 250-300g were used (n=6-8/group). All surgeries 
were performed under ketamine and xylacine anaesthesia (90/10 mg/kg i.p.). The sciatic 
nerve was surgically exposed at the midthigh and carefully freed from adherences to 
surrounding tissues. Passive devices of polyimide 20 mm long, 200 µm wide and 10 µm thick  
(Fig. 1A) were inserted longitudinally in the tibial branch of the sciatic nerve with the help of a 
straight needle attached to a 10-0 loop thread (STC-6, Ethicon). The thread is passed 
between the two arms of the device and pulls the arrow-shaped center of the electrode strip 
(Fig. 1B-C), as previously described for the insertion of LIFEs (9). Longitudinal implant was 
chosen because of its better reproducibility in comparison with transversal implant, and to 
better study only the FBR inside the nerve. A group of animals underwent a sham operation 
with the same procedures but leaving no implant inside the nerve.  
Adequate measures were taken to reduce the number of animals used and to minimize pain 
and animal discomfort during surgery and in the postoperative follow-up. After surgeries 
animals were left to recover under a warm environment and were housed at 22±2ºC under a 
12:12h light cycle with food and water access ad libitum. All experimental procedures 
performed were approved by the Ethical Committee of the Universitat Autònoma de 
Barcelona in accordance with the European Communities Council Directive 2010/63/EU.  
After 1, 2, 4 days and 2, 4, 8, 16 and 32 weeks post implant, animals were deeply 
anesthetized with an overdose of pentobarbital and perfused transcardially with 4% PFA in 
phosphate buffer (PB). After the perfusion, the sciatic nerve segment including the implant 
was collected and kept in 30% sucrose in PB for immunohistochemistry, in 70% ethanol for 
paraffin embedding or in 3%glutaraldehyde-3% paraformaldehyde in PB for light and electron 
microscopy.  
 
   
2.2 Functional evaluation 
The functional properties of the nerves that had been implanted were evaluated by means of 
nerve conduction, algesimetry and locomotion tests along time after the implant. Nerve 
conduction test was performed by stimulating the sciatic nerve proximally with single 
electrical pulses and recording the compound muscle action potentials (CMAPs) of the 
gastrocnemius medialis (GM) muscle as previously described (18). The nociceptive threshold 
to mechanical stimuli was evaluated by means of an electronic Von Frey algesimeter 
(Bioseb, Chaville, France) following the same protocol described before (32). Rats were 
placed on a wire net platform in plastic chambers, and a metal tip applied to the sole of the 
hindpaw until the rat withdrew the paw in response to the stimulus. The walking track test 
was performed to assess locomotor function after the implant. The plantar surface of the 
hindpaws was painted with black ink and the rat was left to walk along a corridor. The print 
length, the distance between the 1st and 5th toes and between the 2nd and 4th toes were 
measured to calculate the Sciatic Functional Index (SFI) (33). 
 
2.3 Morphological evaluation  
In order to evaluate the microstructure of the implanted nerves and the myelinated nerve 
fibers, segments fixed in 3% glutaraldhyde-3% paraformaldehyde were postfixed in 2% OsO4 
for 2h, dehydrated through ethanol series and embedded in epon resin. Semithin sections 
(0.5 µm thick) were stained with toluidine blue and examined by light microscopy. The 
number of myelinated fibers in the implanted tibial nerve was counted in images taken at 
100x chosen by systematic random sampling of squares representing at least 30% of the 
nerve cross-sectional area. The cross-sectional area of the whole sciatic nerve was 
measured at 4x with a microscope BX51 (Olympus) and a DP73 digital camera (Olympus) 
and the total number of myelinated fibers estimated. The thickness of the deposited tissue 
around the implant was measured as the distance between each side of the device and the 
closest myelinated axon, using ImageJ software (34).   
   
Transmission electron microscopy (TEM) was used to evaluate the ultrastructure of the 
tissue and collagen deposition around the polyimide device in transverse nerve sections. 
Ultrathin sections of the entire nerve were cut, mounted on formvar 200 mesh copper grids 
and contrasted with uranyl acetate/lead citrate. A TEM microscope (JEM 1400) was used to 
take pictures of the area with the implanted device, to analyse the encapsulating tissue and 
the surrounding nerve fibers at different time points. 
 
2.4 Immunohistochemistry 
Nerve segments containing the implanted polyimide device were serially cut in 15 µm thick 
sections in 10 slides with 12 slices each with a cryostat (Leica CM190, Leica Microsystems). 
Nerve sections were blocked with normal donkey serum and incubated overnight at 4ºC with 
primary antibodies rabbit anti-iba1 (Wako, 191947, 1:500) and mouse anti-CD-68 clone ED1 
(abcam, ab31630, 1:500) for macrophages and mouse anti-CD90 clone OX-7 (BD 
Pharmingen, 554897, 1:150) for fibroblasts. Slides were then washed with 0.1% Tween 20 
buffer solution and incubated with AlexaFluor 594 donkey anti-rabbit (Invitrogen, A21207, 
1:200) and 488 donkey anti-mouse (Invitrogen, A21202, 1:200) secondary antibodies for 1 h 
at room temperature. Finally, sections were mounted with mowiol containing DAPI (0.1 
μg/ml, Sigma).  
To quantify the amount of infiltrating macrophages, images of the whole tibial nerve with iba1 
or ED1 immunostaining were taken with an epifluorescence microscope BX51 (Olympus) 
attached to a DP73 digital camera (Olympus) and equally treated to adjust brightness and 
contrast. Then, the background was subtracted and a threshold of detection and binarization 
was applied. Iba1 or ED1 positive cells were counted in the whole area of the tibial nerve, 
excluding the implant device and the tissue capsule using the command "Analyze Particles" 
of ImageJ.  
 
   
2.5 Paraffin embedding and hematoxylin-eosin staining 
To determine the amount of foreign body giant cells (FBGCs) around the implant, nerve 
segments containing the implanted device were dehydrated with increasing ethanol series, 
followed by increasing xylene series and finally embedded in paraffin. Then, 5 µm thick serial 
sections were cut with a microtome (Leica RM 2255). To study FBGCs, slides were 
deparaffinized using two xylene rinses of 15 min each and rehydrated with decreasing 
ethanol series and 5 min in water. Then, slides were immersed in hematoxylin Harris solution 
(Fluka, Sigma) for 7 min and washed in water followed by 1% HCl in ethanol solution for 20 
sec. Finally, sections were washed again with water and stained with Eosin Y (Merck 
Millipore) for 5 min. Sections were dehydrated with series of graded ethanol rinses and 
mounted with DPX (Sigma). Then, the number of FBGC was counted under the microscope 
in each stained section, and expressed as FBGC per mm of implant length. Moreover, 
pictures of every FBGC were taken and the diameter was measured with ImageJ. 
 
2.6 Statistical analysis 
Results are expressed as mean ± SEM. Means were compared with one or two-way ANOVA 
followed by Bonferroni post hoc test for differences between groups or times. To quantify the 
linear relationship between two variables, the Pearson's correlation coefficient and the P-
value of the Fisher test were calculated. All analysis were conducted by using GraphPad 
Prism software. Statistical significance was considered when p < 0.05. 
 
  
   
3. Results 
3.1 Longitudinal neural implants do not cause damage in the implanted nerves 
Functional studies performed along time (from week 1 up to month 8) postimplant did not 
show any changes in nerve conduction, pain thresholds or locomotion (Supplementary Fig. 
1). Histological evaluation of polyimide implanted nerves revealed that all the implanted 
devices were placed within the tibial nerve (Fig. 2A). Light microscopy observations showed 
a normal fascicular architecture and axonal morphology of both implanted and sham nerves, 
similar to intact sciatic nerves (Fig. 2A-B) and the number of myelinated fibres showed no 
differences between groups (Fig. 2C). Moreover, no signs of axonal degeneration or 
demyelination due to the surgery or the implanted device within the nerve were found, 
indicating that the implant model used was useful to assess the FBR to the polyimide device, 
without confounding factors that might be due to tissue damage. 
 
3.2 Nerve response and tissue capsule formation  
The tissue capsule formed around the implant was evaluated under light microscopy. 
Whereas in the sham nerves there was no evidence of wound or tissue aggregation at any 
time point (Fig. 3B), the surrounding of the implant was rapidly modified in the device 
implanted nerves (Fig. 3A). Quantification of tissue deposition thickness around the implant 
exhibited a gradual increase from 2 days to 2 weeks post-implant when it reached its 
maximum, and a slight decrease and compaction thereafter (Fig. 3C).  
Detailed analysis of the encapsulating tissue under light and transmission electron 
microscopy showed several changes in the surroundings of the device. Thus, at day one only 
some erythrocytes could be seen near the implant and axons were still in close contact with 
the polyimide. After 4 days, some amoeboid cells had already arrived to the polyimide device 
vicinity (Fig. 4A) and started to be organized creating a small gap between the implant and 
the axons. After 2 and 4 weeks post implant, the capsule that separated the axons and the 
   
polyimide implant appeared as a more compacted tissue containing mainly amoeboid-
shaped cells and the characteristic collagen deposition of the endoneurium can no further be 
distinguished in the surroundings of the implant (Fig. 4B&D). At 8 weeks, two zones could be 
differentiated in the encapsulating tissue, with an inner area stocked with amoeboid cells as 
in the previous time points and an outer region composed of layers of parallel spindle-shaped 
cells (Fig. 4C&E). While this disposition was very similar after 16 weeks, the presence of 
amoeboid cells seemed to slightly decline, but it was at 32 weeks post implant that only 
spindle-shape cells were seen in the capsule (Fig. 4F) with no presence of amoeboid cells. 
Moreover, these changes in the cellular type from 8 to 32 weeks also correlated with a 
further organization of the extracellular matrix of the capsule, with an increasing deposition 
and gradual organization of new collagen fibers that progressively invaded the area former 
occupied by spindle-shaped and amoeboid cells (Fig. 4D-F and insets).  
 
3.3 Cellular characterization of the FBR 
To evaluate the inflammatory response due to the surgery or the implant, we assessed the 
presence of Iba1 labeled macrophages in the whole tibial nerve. Whereas in intact nerves a 
few macrophages were seen, the number of Iba1 positive macrophages started to increase 
within the implanted nerves one day after surgery both in polyimide device and in sham 
groups (Fig. 5A-B). The inflammatory response caused solely by the surgery, evaluated in 
sham rats, peaked at 4 days and decreased noticeably at 2 and 4 weeks, reaching similar 
values than intact animals from week 8 onwards (Fig. 5C). In contrast, the inflammatory 
reaction due to the implanted device peaked at 2 weeks and took more time to resolve, with 
a slight decrease at 4 weeks that persisted 8 weeks after the implant. Finally, at week 16 and 
32, the number of macrophages showed a further decrease but with still significantly more 
Iba1+ cells than sham and intact animals (Fig. 5C). Moreover, to characterize these infiltrating 
macrophages, the amount of macrophages that presented positivity for the CD-68 ED1 
antigen (Supplementary Fig. 2A) was quantified. As expected, all the CD-68 positive cells 
   
were also stained with the Iba1 antibody, while several Iba1+ macrophages did not express 
the ED1 antigen, showing a similar pattern of evolution than Iba1 labeling (Supplementary 
Fig. 2B) with a peak at 2 weeks after the implantation and a gradual decline up to 8 months. 
Hence, the amount of CD-68+ and Iba1+ cells followed a direct relationship (supplementary 
Fig. 2C) with a slope statistically significant different from zero (F-test). 
To further investigate how the tissue capsule is formed around the implant, we focused on 
the two main cell populations involved in the FBR process: macrophages and fibroblasts (35). 
In the host response in the implanted peripheral nerves, macrophages were the first cells to 
arrive (Fig. 6A) and rapidly surround the device from day 2-4 up to 4 weeks after implant 
(Fig. 6B-E). Indeed, after 2 and 4 weeks, the capsule around the device was mainly formed 
by compacted macrophagic cells expressing Iba1 in close contact with the device, in a 
similar disposition of the round-shape cells observed by TEM in figure 4. By week 8, some 
CD90+ fibroblasts started to appear in the edge of the capsule, between the inner 
macrophage layer and the surrounding nerve fibres (Fig. 6F), confirming the observations of 
light and electron microscopy. After 16 weeks, although the number of cells in the capsule 
decreased, Iba1 positive macrophages were still in contact with the device and CD90 
positive fibroblasts were in the outer layer of the capsule, in contact with nerve fibres (Fig. 
6G). After 32 weeks of implant, most cells in the capsule were CD90 positive fibroblasts 
within a well-organized extracellular matrix (Fig 6H).  
Finally, the amount of FBGC was also measured as another hallmark of FBR. These cells 
resulting from macrophage fusion appeared soon after the polyimide device implantation and 
its number increased over time (Fig. 7A-B). The FBGC seen in this model had many nuclei 
mainly in the cellular periphery (36), as expected with the presence of foreign bodies. By week 
2 these cells were easily recognizable around the implant, becoming stabilized in number 
and size (Fig. 7B-C) up to 8 weeks. From week 16 onwards, the amount of these cells 
started to decline concomitantly with the emergence of fibroblasts and the decline of 
macrophages both in the nerve and the capsule.  
   
4. Discussion 
After the implant of any biomaterial in the body, early and chronic cellular and tissue 
responses occur (19),(37). These events include an inflammatory response, foreign body 
reaction, and fibrous encapsulation of the implanted devices (38),(39). The peripheral nervous 
system is not an exception (9) and it is a serious problem when the active sites of implanted 
intraneural interfaces have to be in intimate contact with nerve fibers to have a proper 
functionality. Although many studies have reported good results regarding stimulation and 
recording of nerve signals in short-term studies, a progressive loss of function of intraneural 
electrodes that reduce the useful life of the interface has been usually reported and 
attributed, at least in part, to the FBR (13),(14),(16),(29).  
Some reports have characterized the FBR to intraneural implants in cats (30) or in humans (28), 
but these studies were conducted after implantation of rigid multielectrode Utah slanted 
arrays and the stiffness of these electrodes has been reported to contribute to traumatic 
nerve injuries produced by mechanical tension and an increased FBR (40). However, here we 
describe in detail the progression of the FBR to longitudinal intraneural devices fabricated 
with polyimide, a flexible material that can deform in 3D and adapt with the nerve (41), widely 
used in the fabrication of nerve electrodes implanted in rats (18),(42),(43) and in humans(13)–(15). 
Therefore, the information in this study may help to design novel strategies for modulating 
the FBR against electrodes placed within the peripheral nerve. Besides, although the central 
nervous system reacts different to neural implants due to the different populations implicated 
in this response (26),(44),(45), the information provided here could also be used to understand 
and treat similar reactions in the CNS. 
Unlike other fibrotic responses in pathological conditions where scar tissue impairs proper 
function of the organ (46),(47), our results showed that the new tissue formation in the 
peripheral nerve does not have a negative impact on its function after careful implantation, as 
previously reported when implanting longitudinal (LIFE) (9) or even transversal (TIME) 
electrodes (10). Electrophysiological tests of the implanted nerves did not show alterations in 
   
the onset and the amplitude of the evoked compound action potentials along the 8 months of 
implantation. Besides, there were no functional alterations observed in nociceptive and in 
locomotion tests. These results were corroborated by histological observations of implanted 
and sham nerves, where the normal fascicular architecture was preserved, and no evidences 
of axonal damage and distal degeneration were observed at all the studied time points. This 
is an important point, since the longitudinal implant of the thin film polyimide device, 
mimicking the use of tf-LIFEs, allowed us to investigate the FBR against the device, without 
relevant contributions of tissue damage due to the surgical procedure or to the mechanical 
stress of connected wires.  
In order to understand how the FBR evolves, we first studied the infiltration of macrophages 
in the nerve as a sign of the immune response. Whereas in the sham group the inflammatory 
reaction was low and took short time to resolve, in the device implanted group there were 
more infiltrating macrophages and the inflammation was longer in time, becoming chronic. 
This evolution corresponds to the FBR widely studied in other tissues, which normally has an 
acute inflammatory phase that becomes chronic with time (19). Moreover, the evolution of 
ED1+ macrophages labelling suggests that there are no changes in the responsiveness of 
these cells with time as they appear and disappear following the same pattern of evolution 
than the pan macrophage marker Iba1(48). Hence, the linear correlation of ED1/Iba1+ cells 
indicates that after the implantation of PI longitudinal devices, there is not a differential rate of 
macrophage reactivity rather than an increase and a subsequent decrease of both Iba1+ and 
ED1+ macrophages.  
We also assessed the progressive formation of an encapsulating tissue around the polyimide 
device. One day after the implantation the body started to react against the foreign device 
with changes in the surrounding as seen by electron microscopy. Nevertheless, there was no 
real capsule until four days and the thickness peaked by 2 weeks. From week 4 to the end of 
the follow-up, the capsule was progressively decreasing in thickness until stabilization. This 
dynamic in the capsule formation is coincident in time with the infiltration of macrophages in 
   
the nerve due to the implant described here which also peaked after 2 weeks and started to 
decrease thereafter (49). It has been shown that macrophages and phagocytes are related 
with the nature of the material implanted and its degradation dynamics (50),(51). Thus, 
biodegradable materials would stimulate a more M1 and phagocytic environment to eliminate 
the implant. In contrast, non-biodegradable materials would stimulate a more M2, pro-fibrotic 
and tissue remodeling environment, with the contribution of FBGC and matrix deposition. In 
fact, fused macrophages forming FBGCs were found surrounding the implanted device as 
early as 1 day after the implant contributing to the FBR and their size did not change 
substantially throughout the study. The amount of these cells increased gradually to reach a 
maximum at 2 weeks, similar to the maximum of Iba1+ cells and capsule thickness but the 
number of these declined more slowly than macrophages in the nerve at 4 or 8 weeks. And it 
is only at 16 or 32 weeks, when macrophages have practically disappeared that the 
presence of these cells also decline as a hallmark of the chronic phase of the FBR (39). 
However, FBGCs are found only within the tissue capsule where tissue reactivity and 
inflammation is higher than within the nerve endoneurium, and these cells have been linked 
to the tissue formation around implants (52): Therefore, the subsequent decline of FBGC after 
macrophage drop could indicate an intermediate step between macrophage to fibroblast 
presence around the implant when the tissue capsule switches from a phagocytizing state to 
a barrier forming state due to the presence of a non-phagocytable foreign body. Taking our 
results into account, polyimide intraneural implants could be stimulating the second scenario, 
regarding the presence of FBGC and the early resolution of the inflammatory response in the 
nerve in comparison to the remodeling response. Nevertheless, a deeper analysis of the 
molecular environment and the degradation process of the different implanted devices would 
further increase the understanding of the relationship between the foreign body and the 
peripheral nerve.  
Moreover, the changes in the cellular and the molecular characteristics of the capsule in the 
nerve seem to follow a similar pattern as the FBR in subcutaneous implants (38) although the 
   
evolution may be different from what has been previously described for FBR in the 
nerve(42),(53). Thus, during the acute inflammatory phase of the FBR, macrophages and other 
immune cells, such as mast cells and neutrophils, start to surround the foreign body and to 
adsorbed proteins on the device surface in a process called biofouling that will stimulate the 
subsequent phases (38). The accumulation of these cells around the device would contribute 
to the pro-inflammatory environment which leads the subsequent chronic inflammation and 
tissue remodeling phase (19). During the first weeks after the intraneural implants, there is a 
marked presence of round-shaped Iba1+ macrophages surrounding the implanted device. 
Besides, no evidence of organized matrix or collagen production near the device can be 
seen under electron microscopy. Progressively over time, more macrophages surround the 
device and, from 8 weeks onwards, fibroblasts arise at the edge of the capsule. Later on, the 
occurrence of macrophages starts to decline while fibroblasts increase their presence at 16 
weeks. Finally, 8 months after the implantation, macrophages almost disappear from the 
encapsulating tissue and fibroblasts become more numerous and form a permanent 
connective capsule. These changes in the cellularity of the capsule correlate with an 
increase in collagen production and organization of the matrix. While other studies of the 
FBR to intraneural microelectrodes (29),(30) have shown the presence of macrophages 
surrounding the device but no alterations in the axons near the electrode, here we also 
demonstrate the implication of fibroblasts in the formation of the capsule and how it coincides 
in time with the increase in organization of the new extracellular collagen matrix.  
In conclusion, several efforts have been reported to improve biomaterial characteristics and 
to understand the underlying mechanisms of the FBR against implantable devices for other 
tissues than the nerve (50),(54),(55). Our results describe how the FBR against a polyimide 
implant in the peripheral nerve occurs and which are the main players. The understanding of 
these changes will let to a better development of new strategies that would reduce the FBR 
against intraneural implants and thus lengthen their lifespan.  
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Figure captions 
Figure 1. Surgical procedure. (A) Photograph of the longitudinal device implanted (bottom) 
and the implantation needle used (above). (B) Needle used for the implantation piercing 
(arrowhead) the sciatic nerve (arrow) of a rat. (C) Device implanted (arrow points to the 
triangle base) in the sciatic nerve. Scale bar in (B-C) = 1mm. 
 
Figure 2. Histological evaluation of implanted nerves. (A) Low and (B) high magnification 
images of semithin sections of sham (above) and implanted (below) nerves after 2 weeks. 
(C) Quantification of myelinated fibers in sham and implanted nerves. The dotted line 
indicates the mean number of intact tibial nerves. Scale bar in (A) = 200μm and (B) = 10μm. 
 
Figure 3. Histological progression of capsule tissue around the implants. (A) 
Representative images of time progression of the capsule around polyimide implants. (B) No 
signs of tissue aggregation can be observed in sham nerves. (C) Measurements of capsule 
thickness along time. *p<0.05 vs 2weeks. Scale bar = 50μm.  
 
Figure 4. Tissue capsule development around the implant (bottom). (A-F) Magnification 
of semithin sections showing changes in the capsule. At (A) day 1, erythrocytes (arrow) can 
be seen near the implant. After 4 days, 2 and 4 weeks (B-D) amoeboid cells (asterisks) are 
forming the capsule. After 8 and 16 weeks (E & F), the capsule is already compacted and 
spindle-shape cells (arrowheads) are seen within. (D-F) Representative transmission 
electron microscopy images taken at different time points with the amoeboid-shaped cells 
(asterisks) in the inner zone of the capsule at 2 weeks and the spindle-shaped cells 
(arrowheads) in the outer zone at 8 and 32 weeks. Insets of G-I show high-magnification 
view of changes in collagen matrix deposition at 2, 8 and 32 weeks. Scale bar = 10μm (A-F), 
5μm (G-I), 2μm (insets). 
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Figure 5. Inflammatory cells in the implanted nerves. Representative images of 
macrophages labelled with Iba1 at different times points in (A) implanted and (B) sham 
nerves. (C) Quantification of the number of Iba1 positive cells along time in implanted and 
sham animals. Dotted line indicates the mean of intact nerves.*p<0.05 vs sham. #p<0.05 vs 
2weeks. Scale bar = 100 µm.  
 
Figure. 6. Cellular events in the tissue capsule around the device. Representative 
confocal images of cells in the capsule from 1 day to 32 weeks. Macrophages (red) are in 
contact with the device until 16 weeks. Fibroblasts (green) appear at 4-8 weeks and are 
located in the periphery of the capsule, in contact with nerve fibres. Scale bar = 15 µm. 
 
Figure. 7. Foreign body giants cells as a hallmark of the FBR. (A) Presence of FBGC in 
the surface of the device observed with Hematoxilin-Eosin at different time points. (B) 
Number and (C) diameter of FBGC on the device along time. *p<0.05 vs 2weeks. Scale bar 
= 15 µm. 
 
Supplementary figure 1. Functional evaluation of implanted nerves. No alterations were 
found in the (A) amplitude or (B) initial latency of the gastrocnemius compound muscle action 
potential (CAMP) of implanted and sham animals. (C) Pain threshold assess by Von Frey 
mechanical algesimetry in the central area of the paw. (D) SFI of sham and implanted 
animals. Dotted lines indicate values from intact animals.  
 
Supplementary figure 2.  ED1-Iba1 macrophage staining over time. (A) Representative 
images of ED1 (green) and Iba1 (red) labeling after 2 weeks of implant, cell nuclei can be 
seen in blue after DAPI staining. (B) Quantification of the number of ED1 positive cells and 
Iba1 positive cells over time. (C) Correlation between ED1 and Iba1 positive cells. The solid 
   
grey line represents the linear regression (slope significantly different from zero, p<0,001), 
while the dotted line represents the 95% confidence interval. Scale bar = 200 µm. 
